The incidence of type 1 diabetes in children under 15 years of age is rising again-a nationwide study.

Authors:
Roche EF; McKenna AM; O'Regan M; Ryder KJ; Fitzgerald HM and 1 more

Journal:
Eur J Pediatr

Publication Year: 2023

DOI:
10.1007/s00431-023-05125-7

PMCID:
PMC10587220

PMID:
37550598

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Eur J Pediatr

Abbreviation: Eur J Pediatr

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pediatrics

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Acute bacterial lymphadenitis in children: a retrospective, cross-sectional study.
Howard-Jones AR; Al Abdali K; Britton PN. (2023) - Transparency Score: 3/6
Acute kidney injury in infants hospitalized for viral bronchiolitis.
Marzuillo P; Di Sessa A; Golino R and 6 more (2023) - Transparency Score: 3/6
Age-dependent normal values for the 'Infant Gastroesophageal Reflux Questionnaire Revised'.
van Lennep M; Lansink F; Benninga MA and 1 more (2023) - Transparency Score: 3/6
Analysis of serum insulin-like growth factor-1, fibroblast growth factor 23, and Klotho levels in g…
Liu Y; Cheng Y; Sun M and 2 more (2023) - Transparency Score: 3/6
Apneas requiring respiratory support in young infants with COVID-19: a case series and literature r…
Paolin C; Zanetto L; Frison S and 5 more (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approvalEthical approval for this study was granted by the SJH/AMNCH Joint Research Ethics Committee. Consent to participateWritten informed consent was obtained from parent(s) of each child participant. Consent for publicationNot applicable. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

Evidence found in paper:

"Funding Open Access funding provided by the IReL Consortium National Children’s Hospital Foundation (NCHF). The ICDNR is supported equally by an unrestricted grant from Novo Nordisk Ltd and an unrestricted grant from Abbott Laboratories Ireland Ltd. "

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025